Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-21
DOI
10.1038/s41375-020-0830-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients
- (2018) Artur Jurczyszyn et al. BRITISH JOURNAL OF HAEMATOLOGY
- Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14)
- (2018) Tomas Jelinek et al. AMERICAN JOURNAL OF HEMATOLOGY
- Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs
- (2018) Lohith Gowda et al. BONE MARROW TRANSPLANTATION
- Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents
- (2018) Roberto Mina et al. CANCER
- Combination therapy incorporating Bcl-2 inhibition with Venetoclax for the treatment of refractory primary plasma cell leukemia with t (11;14)
- (2017) Wilson I. Gonsalves et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome
- (2016) Bruno Royer et al. JOURNAL OF CLINICAL ONCOLOGY
- International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
- (2016) Shaji Kumar et al. LANCET ONCOLOGY
- Trends in survival of patients with primary plasma cell leukemia: a population-based analysis
- (2014) W. I. Gonsalves et al. BLOOD
- Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group
- (2013) Eirini Katodritou et al. AMERICAN JOURNAL OF HEMATOLOGY
- Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia
- (2013) P Musto et al. LEUKEMIA
- Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols
- (2012) S Z Usmani et al. LEUKEMIA
- Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
- (2012) C Fernández de Larrea et al. LEUKEMIA
- Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party
- (2011) G. D'Arena et al. ANNALS OF ONCOLOGY
- Clinical Outcomes of Patients With Plasma Cell Leukemia in the Era of Novel Therapies and Hematopoietic Stem Cell Transplantation Strategies: A Single-Institution Experience
- (2011) Daniel Lebovic et al. Clinical Lymphoma Myeloma & Leukemia
- Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research
- (2011) A Mahindra et al. LEUKEMIA
- Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience
- (2011) H Avet-Loiseau et al. LEUKEMIA
- Primary plasma cell leukemia and autologous stem cell transplantation
- (2010) M. B. Drake et al. HAEMATOLOGICA
- Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
- (2010) Christian Gisselbrecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Primary plasma cell leukemia
- (2009) Giridharan Ramsingh et al. CANCER
- Frequent upregulation ofMYCin plasma cell leukemia
- (2009) Laura Chiecchio et al. GENES CHROMOSOMES & CANCER
- Lenalidomide, Melphalan, and Prednisone Association Is an Effective Salvage Therapy in Relapsed Plasma Cell Leukaemia
- (2009) Tommasina Guglielmelli et al. Journal of Oncology
- Genetic aberrations and survival in plasma cell leukemia
- (2008) R E Tiedemann et al. LEUKEMIA
- Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia
- (2008) Hong Chang et al. LEUKEMIA RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now